Free Trial
NASDAQ:BHST

BioHarvest Sciences (BHST) Stock Price, News & Analysis

BioHarvest Sciences logo
$11.80 +0.80 (+7.27%)
As of 09/24/2025 04:00 PM Eastern

About BioHarvest Sciences Stock (NASDAQ:BHST)

Advanced

Key Stats

Today's Range
$11.03
$12.00
50-Day Range
$6.84
$11.80
52-Week Range
$4.66
$12.00
Volume
173,430 shs
Average Volume
38,548 shs
Market Capitalization
$193.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.67
Consensus Rating
Buy

Company Overview

BioHarvest Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
35th Percentile Overall Score

BHST MarketRank™: 

BioHarvest Sciences scored higher than 35% of companies evaluated by MarketBeat, and ranked 757th out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    BioHarvest Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Upside Potential

    BioHarvest Sciences has a consensus price target of $13.67, representing about 15.8% upside from its current price of $11.80.

  • Amount of Analyst Coverage

    BioHarvest Sciences has received no research coverage in the past 90 days.

  • Read more about BioHarvest Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for BioHarvest Sciences are expected to grow in the coming year, from ($0.80) to ($0.28) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of BioHarvest Sciences is -16.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of BioHarvest Sciences is -16.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    BioHarvest Sciences has a P/B Ratio of 147.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about BioHarvest Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    0.12% of the float of BioHarvest Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    BioHarvest Sciences has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    BioHarvest Sciences does not currently pay a dividend.

  • Dividend Growth

    BioHarvest Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.12% of the float of BioHarvest Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    BioHarvest Sciences has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • News Sentiment

    BioHarvest Sciences has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for BioHarvest Sciences this week, compared to 2 articles on an average week.
Receive BHST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioHarvest Sciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BHST Stock News Headlines

BioHarvest balance sheet gets $14.7m boos, including $11m of new investment
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social Security? What we just discovered in Washington will stun even the most seasoned insiders.tc pixel
BioHarvest Sciences: Growth Story Meets Valuation Reality
See More Headlines

BHST Stock Analysis - Frequently Asked Questions

BioHarvest Sciences' stock was trading at $6.18 at the start of the year. Since then, BHST stock has increased by 90.9% and is now trading at $11.80.

BioHarvest Sciences Inc. (NASDAQ:BHST) released its quarterly earnings data on Monday, August, 11th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.11) by $0.04. The firm earned $8.52 million during the quarter, compared to analyst estimates of $8.53 million. BioHarvest Sciences had a negative net margin of 39.95% and a negative trailing twelve-month return on equity of 11,357.84%.
Read the conference call transcript
.

Top institutional investors of BioHarvest Sciences include Magnus Financial Group LLC (0.43%) and True North Advisors LLC (0.13%).

Shares of BHST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/11/2025
Today
9/25/2025
Next Earnings (Estimated)
11/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BHST
Previous Symbol
NASDAQ:BHST
CIK
1723464
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$15.00
Low Price Target
$12.00
Potential Upside/Downside
+15.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.91 million
Net Margins
-39.95%
Pretax Margin
-39.67%
Return on Equity
-11,357.84%
Return on Assets
-39.94%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.60
Quick Ratio
0.36

Sales & Book Value

Annual Sales
$25.19 million
Price / Sales
7.69
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.08 per share
Price / Book
147.50

Miscellaneous

Outstanding Shares
16,420,000
Free Float
N/A
Market Cap
$193.76 million
Optionable
N/A
Beta
0.68
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:BHST) was last updated on 9/25/2025 by MarketBeat.com Staff
From Our Partners